News tagged ‘BasicResearch’ clear
- A study documents the connection between increased levels of epoxyeicosatrienoic acids (EET) lipids and cancer growth and metastasis opening the door to a new avenue for cancer treatment.
- Researchers have found several new altered genes that drive chronic lymphocitic leukemia through powerful DNA sequencing, a finding that could potentially help doctors predict whether a patient’s disease will progress rapidly or remain indolent for years.
Tags: BasicResearch, Leukemia
- Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenström's macroglobulinemia, a rare form of lymphoma that has eluded all previous efforts to find a genetic cause.
Tags: BasicResearch, Lymphoma
- Scientists have created a "cocktail" combination of four antigenic peptides derived from myeloma cells they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the blood cancer.
Tags: BasicResearch, MultipleMyeloma
- "Twinning" U.S.-based and Rwandan physicians in a team approach has shown to improve lymphoma outcomes in children in a country lacking any specialists in children's cancers.
Tags: BasicResearch, ChildhoodCancer, Lymphoma
- A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases.
Tags: BasicResearch, StemCellTransplant
- Researchers have identified a mechanism that triggers inflammation in the liver and transforms normal cells into cancerous ones, a finding that could lead to the treatment or prevention of liver cancer.
Tags: BasicResearch, LiverCancer
- In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.
Tags: BasicResearch, GraftVersusHost, ImmuneSystem
- A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston
Tags: BasicResearch, Radiation
- Dana-Farber scientists have devised a test that can predict how effective chemotherapy will be by determining whether tumor cells are "primed" for death. The discovery suggests it may be possible to predict which patients will likely benefit from chemo, as well as to make some chemo more effective.
Showing 41-50 of 110 items